Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
17,410,719
-
Total 13F shares
-
854,906
-
Share change
-
+69,576
-
Total reported value
-
$1,821,034
-
Price per share
-
$2.13
-
Number of holders
-
14
-
Value change
-
+$130,230
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) as of Q4 2025
As of 31 Dec 2025,
ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
854,906 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BlackRock, Inc., CITADEL ADVISORS LLC, NORTHERN TRUST CORP, XTX Topco Ltd, JANE STREET GROUP, LLC, and MORGAN STANLEY.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.